本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Milestone Pharmaceuticals Inc.

1.26
+0.10008.62%
成交量:196.22万
成交额:229.09万
市值:6,722.60万
市盈率:-1.89
高:1.26
开:1.17
低:1.09
收:1.16
数据加载中...
2021/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/11/12

重要事件披露

8-K - Current report
2021/11/04

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/10/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/21

重要事件披露

8-K - Current report
2021/06/02

重要事件披露

8-K - Current report
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/17

重要事件披露

8-K - Current report
2021/03/30

重要事件披露

8-K - Current report
2021/03/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/29

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals